Vaccines are playing a critical role, but previous pandemics reached their conclusions by different means altogether. | Continue reading
The cells organized themselves into a three-dimensional structure, complete with a single chamber reminiscent of a human heart. | Continue reading
Scientists say there are good reasons for fully vaccinated people to hang on to their mask stash a while longer. | Continue reading
Early reports suggested that SARS-CoV-2 aggressively causes myocarditis, or "Covid heart." The real verdict is in: It doesn't. | Continue reading
The decision by the Biden administration to support the proposal comes after months of fruitless talks at the World Trade Organization. | Continue reading
Hypernationalism helped fuel India's Covid-related devastation, but the real problem is historical neglect of its health care systerm. | Continue reading
Stanford University researchers have decoded the chemical and physical signals that trigger a particular type of skin cell to produce scars. | Continue reading
There is evidence that for-profit nursing homes and hospices are putting profits ahead of people, taking a deadly toll during the pandemic. | Continue reading
Important public health lessons from the Civil War became mainstream 20th century practices. Then many of them fell by the wayside. | Continue reading
New research looks at how psilocybin — the active ingredient in psychedelic mushrooms — compares to a commonly prescribed antidepressant. | Continue reading
Scientists have created the first embryos that were part human and part monkey and kept them alive for up to 20 days in laboratory dishes. | Continue reading
Paying for health care with a fee-for-service model incentivizes billable treatments over healthy and efficient outcomes. | Continue reading
The narrative about long Covid, a disease linked to the SARS-CoV-2 virus, and about long-haulers may be getting ahead of the evidence. | Continue reading
Internal documents and interviews with former IBM Watson Health employees point to a leadership team that prioritized publicity over science. | Continue reading
As vaccination rates pick up, we look at the logistics that make millions of doses a day possible. | Continue reading
In more than half of the cases, the editing caused unintended changes, such as loss of an entire chromosome or big chunks of it. | Continue reading
Gov. Andrew Cuomo’s nursing home policy mistakes offer lessons on ethical policymaking in times of crisis. | Continue reading
Relying on an assumption it had to know was wrong, the CDC erroneously estimated a one-year decline in life expectancy in 2020. | Continue reading
The platform, Global.health, will enable open access to 10 million anonymized Covid-19 records from 160 countries. | Continue reading
Pfizer insisted some governments cover the potential costs of civil cases that result from its own acts of negligence, fraud, or malice. | Continue reading
The Covid-19 pandemic is likely responsible for “the majority of the decline,” said Elizabeth Arias, lead author of the report. | Continue reading
Scientists disagree whether the number of lung cancer patients who never smoked is increasing, but the proportion who never did clearly is. | Continue reading
The system uses an Apple Watch accelerometer and gyroscope data to detect certain symptoms of Parkinson's and side effects of treatments. | Continue reading
The one-dose J&J vaccine cleared thresholds originally set by the U.S. Food and Drug Administration for a vaccine to be considered useful. | Continue reading
STAT explains what’s known about the variants, why they’re getting so much attention, and what they mean for the trajectory of the pandemic. | Continue reading
"Having this treatment available for some patients provides an alternative for managing this chronic condition," said FDA's John Farley. | Continue reading
Merck announced it is stopping development of both of the current formulations of the Covid-19 vaccines the company was working on. | Continue reading
Tens of thousands of Covid-19 deaths are going unreported, with far more missed in counties that strongly supported former President Trump. | Continue reading
Colchicine, a drug commonly used to treat gout, could reduce the risk people with mild Covid-19 will need to be hospitalized. | Continue reading
The company believes its antibody could be an option not just to treat Covid-19 but to help prevent it in limited circumstances. | Continue reading
Sharon Begley, whose science journalism career spanned 43 years at Newsweek, the Wall Street Journal, Reuters, and STAT, died Saturday at 64. | Continue reading
Humanity wasn't remotely prepared for SARS-Cov-2 when it emerged late in 2019. We are better prepared for the new virus, B-117 | Continue reading
Vaccine sovereignty symbolizes the vaccine, in this case one for Covid-19, as an instrument of power that is not accessible to everyone. | Continue reading
Some public health experts are expressing mounting frustration with the pace of the Covid-19 vaccine rollout. | Continue reading
When a new viral variant emerges, experts want to know how well it spreads, whether it changes the disease, and whether it affects immunity. | Continue reading
The advent of Covid-19 vaccines is a medical miracle, yet also a tantalizing and dangerous psychological milestone. | Continue reading
A look at how the two authorized vaccines stack up against one another on a host of factors, including efficacy and safety. | Continue reading
A look at how the two authorized vaccines stack up against one another on a host of factors, including efficacy and safety. | Continue reading
The decision will help fuel the effort to rein in a pandemic, but early supplies of the first two Covid vaccines to be cleared remain tight. | Continue reading
The authorization will mark the second Covid-19 vaccine cleared by the agency — and amount to one more step toward curbing the pandemic. | Continue reading
CDC researchers found that nearly 300,000 more people in the U.S. died so far this year than the average number who died in recent years. | Continue reading
As Covid-19 vaccines are shipped, experts appear divided on guidance for those with history of severe allergic reaction. | Continue reading
Officials expect 145 sites to get the vaccine on Monday, with doses arriving at hundreds of other sites throughout the week. | Continue reading
“Anything that’s seen as lifesaving, life-preserving, and that's in short supply creates black markets,” said one ethicist. | Continue reading
The Trump administration invited the leading Covid-19 vaccine manufacturers to a celebratory “vaccine summit” on Tuesday. Neither will attend. | Continue reading
A cascade of events set off by high levels of a stress hormone could cause dormant tumor cells to reawaken to once again cause cancer. | Continue reading
Helen Keipp Talbot raised serious concerns during an ACIP meeting about using Covid-19 vaccines in residents of long-term care facilities. | Continue reading
The board of the new company, Resilience, includes a who’s who of former industry and government officials. | Continue reading